共 229 条
- [1] Zhang J(2005)E14 Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Guidance to industry Fed Regist 70 61134-61135
- [2] Machado SG(2008)Statistical issues including design and sample size calculation in thorough QT/QTc studies J Biopharm Stat 18 451-467
- [3] Malik M(2010)Thorough QT studies. Questions and quandaries Drug Saf 33 1-14
- [4] Garnett CE(2014)Cardiac safety research consortium: can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward Am Heart J 168 262-272
- [5] Zhang J(2015)Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase Clin Pharm Therap 97 326-335
- [6] Darpo B(2014)Comparison of automated measurements of electrocardiographic intervals and durations by computer-based algorithms of digital electrocardiographs Am Heart J 167 150-159
- [7] Garnett C(2006)Precision of QT interval measurement by advanced electrocardiographic equipment Pacing Clin Electrophysiol 29 1277-1284
- [8] Benson CT(2012)Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects Am Heart J 163 912-930
- [9] Keirns J(2013)QT/RR curvatures in healthy subjects: sex differences and covariates Am J Physiol Heart Circ Physiol 305 H1798-H1806
- [10] Leishman D(2004)Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods Ann Noninvasive Electrocardiol 9 48-57